Skip to main content
51°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
March 04, 2025
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Product Safety
Tickers
NNVC
Tirzepatide Weight Loss Injections Savings Program: Eligibility Check Announced
March 04, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Luxenberg Garbett Kelly & George P.C. Addresses Memory Loss After an Accident in Pennsylvania
March 03, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
Nourish House Calls: New Research Challenges Misconceptions About Hormone Therapy in Menopause Treatment
March 03, 2025
Via
Press Advantage
Exposures
Product Safety
GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review
March 03, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
GSK
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
March 03, 2025
Via
Newsfile
Exposures
Product Safety
Tickers
CSE:DMED
CSE:RVV
DGNMF
RVVTF
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
March 03, 2025
Via
Newsfile
Exposures
Product Safety
Tickers
CSE:PHRM
PHRRF
NADIOL Responds to NMN Supplement Industry Shake-Up: Committed to Quality, Transparency & Your Health
March 03, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
March 03, 2025
Via
Newsfile
Exposures
Product Safety
Tickers
ELTP
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) and OS Therapies (NYSE American: OSTX) to Appear on RedChip’s Bloomberg TV Show
February 28, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLDI
OSTX
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
February 28, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
HIMS
LLY
NVO
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print
February 27, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
ALT
IWM
VTI
XBI
Together in the Fight Against Cancer: Thomas’ Story of Community and Care
February 27, 2025
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook
February 27, 2025
Via
Benzinga
Topics
Earnings
Exposures
Financial
Product Safety
Tickers
VTRS
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
February 27, 2025
Via
MarketBeat
Exposures
Product Safety
Tickers
LLY
NVO
REGN
SNY
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
LLY
NVO
Zero Calorie Clean Energy Caffeine Drink For Police & First Responders Announced
February 26, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
How to choose a cleanroom that meets FDA standards?
February 26, 2025
Via
AB Newswire
Exposures
Product Safety
Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
February 26, 2025
Via
MarketBeat
Exposures
Product Safety
Tickers
LLY
NVO
PFE
RHHBY
Arthrosamid Hydrogel Injections, Safe Alternative to Knee Surgery Report Launch
February 25, 2025
Via
Press Release Distribution Service
Exposures
Product Safety
Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says
February 25, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
INSM
RY
TSX:RY
From Desperation to Design: Renowned Jewelry Designer, Danielle Nicole Enright Seeks Her Pay It Forward Angel
February 25, 2025
Via
PRLog
Topics
Product Recall
Exposures
Legal
Product Safety
Loyal Saints: Revolutionizing Dog Nutrition with Premium, Freeze-Dried Raw Food
February 25, 2025
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process
February 25, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CLNN
EXCLUSIVE: After FDA Response, Adial Starts Manufacturing Clinical Supplies For Upcoming Phase 3 Program Of Lead Candidate For Alcohol Use Disorder
February 25, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
ADIL
Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment
February 25, 2025
Via
News Direct
Exposures
Product Safety
Tickers
NLSP
Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review
February 24, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
February 24, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
MDT
FDA Clears Entrada Therapeutics' Early-Stage For Potential Treatment Of Duchenne Muscular Dystrophy
February 24, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
TRDA
FDA Rejects Invivyd's Request To Expand Emergency Authorization For Preventive COVID-19 Antibody For Immunocompromised Patients
February 24, 2025
Via
Benzinga
Exposures
COVID-19
Product Safety
Tickers
IVVD
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.